Blood cancer journal

Publications

volume 14, number 1, 2024

Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiao-Dong Mo
MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study. Blood cancer journal 14 (1) (2024)
Charanpreet Singh, Manpreet Saini, Arihant Jain, Deepesh P Lad, Gaurav Prakash, Alka Khadwal, Shano Naseem, Pankaj Malhotra
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Nadine H Abdallah, Arjun Lakshman, Shaji K Kumar, Joselle Madonna Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Yi Lin, Taxiarchis V Kourelis, Rahma Warsame, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Mode of progression in smoldering multiple myeloma: a study of 406 patients. Blood cancer journal 14 (1) (2024)
Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiao-Dong Mo
MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study. Blood cancer journal 14 (1) (2024)
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guillin Tang, Yosra Aljawai, Hina N Khan, Partow Kebriaei, Hans C Lee, Krina K Patel, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood cancer journal 14 (1) (2024)
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guillin Tang, Yosra Aljawai, Hina N Khan, Partow Kebriaei, Hans C Lee, Krina K Patel, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood cancer journal 14 (1) (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Charanpreet Singh, Manpreet Saini, Arihant Jain, Deepesh P Lad, Gaurav Prakash, Alka Khadwal, Shano Naseem, Pankaj Malhotra
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid. Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Nadine H Abdallah, Arjun Lakshman, Shaji K Kumar, Joselle Madonna Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Yi Lin, Taxiarchis V Kourelis, Rahma Warsame, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Mode of progression in smoldering multiple myeloma: a study of 406 patients. Blood cancer journal 14 (1) (2024)
Nadine H Abdallah, Arjun Lakshman, Shaji K Kumar, Joselle Madonna Cook, Moritz Binder, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Suzanne R Hayman, Francis K Buadi, David Dingli, Yi Lin, Taxiarchis V Kourelis, Rahma Warsame, Peter Leif Bergsagel, Sundararajan Vincent Rajkumar
Mode of progression in smoldering multiple myeloma: a study of 406 patients. Blood cancer journal 14 (1) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guillin Tang, Yosra Aljawai, Hina N Khan, Partow Kebriaei, Hans C Lee, Krina K Patel, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander James Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M Mack, P Brent Ferrell, Yaomin Xu, Cosmin A Bejan, Michael R Savona, Alexander G Bick
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
María Castejón-Griñán, Eliene Albers, Lucía Simón-Carrasco, Paula Aguilera, Mauro Sbroggio, David Pladevall-Morera, Andreas Ingham, Ernest Lim, Alba Guillen-Benitez, Elena Pietrini, Michael Lisby, Ian D Hickson, Andrés J López-Contreras
PICH deficiency limits the progression of MYC-induced B-cell lymphoma. Blood cancer journal 14 (1) (2024)
A Vera de Jonge, J A A Bult, D F E Karssing, Marcel Nijland, Martine E D Chamuleau, Mirian Brink
A MYC-rearrangement is a negative prognostic factor in stage II, but not in stage I diffuse large B-cell lymphoma. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Tiziano Barbui, Alessandra Carobbio
Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients. Blood cancer journal 14 (1) (2024)
Gianpietro C Semenzato, Giulia Calabretto, Antonella Teramo, Vanessa Rebecca Gasparini, Elisa Rampazzo, Gregorio Barilà, Renato Zambello
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders. Blood cancer journal 14 (1) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Naseema Gangat, Omer S Karrar, Aref A Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Tefferi
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 14 (1) (2024)
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study. Blood cancer journal 14 (1) (2024)
Yang Cao, Wenxuan Huo, Jiayu Huang, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Chuanhe Jiang, Xiaoxia Hu, Xiao-Dong Mo
MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study. Blood cancer journal 14 (1) (2024)
Charanpreet Singh, Manpreet Saini, Arihant Jain, Deepesh P Lad, Gaurav Prakash, Alka Khadwal, Shano Naseem, Pankaj Malhotra
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid. Blood cancer journal 14 (1) (2024)
Hira S Mian, Martin F Kaiser, Rafael Fonseca
Translocation t(14;16) in multiple myeloma: gangster or just part of the gang? Blood cancer journal 14 (1) (2024)
Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander James Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M Mack, P Brent Ferrell, Yaomin Xu, Cosmin A Bejan, Michael R Savona, Alexander G Bick
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood cancer journal 14 (1) (2024)
Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander James Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M Mack, P Brent Ferrell, Yaomin Xu, Cosmin A Bejan, Michael R Savona, Alexander G Bick
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood cancer journal 14 (1) (2024)
María Castejón-Griñán, Eliene Albers, Lucía Simón-Carrasco, Paula Aguilera, Mauro Sbroggio, David Pladevall-Morera, Andreas Ingham, Ernest Lim, Alba Guillen-Benitez, Elena Pietrini, Michael Lisby, Ian D Hickson, Andrés J López-Contreras
PICH deficiency limits the progression of MYC-induced B-cell lymphoma. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Tiziano Barbui, Alessandra Carobbio
Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients. Blood cancer journal 14 (1) (2024)
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Elise R A Pennings, Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, Djamila E Issa, Martine E D Chamuleau, Pieternella J Lugtenburg, Marie José Kersten, Avinash G Dinmohamed
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal 14 (1) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)